MARCELO VIEIRA NETTO

Índice h a partir de 2011
10
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/33 - Laboratório de Oftalmologia, Hospital das Clínicas, Faculdade de Medicina

Filtros

Limpar filtros

Configurações

search.filters.applied.f.dateIssued: 2016 ×

Resultados de Busca

Agora exibindo 1 - 3 de 3
  • article 3 Citação(ões) na Scopus
    Intraocular straylight before and after low myopic photorefractive keratectomy with and without mitomycin C
    (2016) TORRICELLI, Andre Augusto Miranda; PAREDE, Tais Renata Ribeiro; NETTO, Marcelo Vieira; CRESTANA, Francisco Penteado; BECHARA, Samir Jacob
    Purpose: To evaluate ocular straylight before and after photorefractive keratectomy (PRK) for low myopia with and without topical mitomycin (MMC) treatment. Methods: Patients who underwent PRK for low myopia were enrolled into the study. PRK without MMC was performed in 21 eyes (12 patients), whereas PRK with topical 0.02% MMC was performed in 25 eyes (14 patients). Both groups were treated using the NIDEK EC5000 excimer laser. Measurements were performed using the C-Quant straylight meter preoperatively and at two and four months postoperatively. Results: The mean patient age was 30 +/- 4 years, and the mean spherical equivalent refractive error was -2.2 +/- 0.75 D. The mean preoperative intraocular straylight values were 1.07 +/- 0.10 in the PRK without MMC group and 1.07 +/- 0.11 log(s) in the PRK with topical MMC group. At two months after surgery, there was a decrease in mean intraocular straylight values in both groups. However, a significant difference was only reached in the PRK with MMC group [0.98 +/- 0.09 log(s), p=0.002] compared with preoperative values, which was likely due to a greater scatter of measurements in the PRK without MMC group [1.03 +/- 0.13 log(s), p=0.082]. At four months postoperatively, ocular straylight values were not significantly different compared with those at baseline in either the PRK without MMC group [1.02 +/- 0.14 log(s), p=0.26] or in the PRK with topical MMC group [1.02 +/- 0.11 log(s), p=0.13]. Conclusion: PRK for low myopia decreases ocular straylight, and MMC application further reduces straylight in the early postoperative period. However, ocular straylight values do not significantly differ at four months after surgery compared with those at baseline.
  • article 47 Citação(ões) na Scopus
    Femtosecond Laser-Assisted LASIK Flap Complications
    (2016) SANTOS, Allisson Mario dos; TORRICELLI, Andre A. M.; MARINO, Gustavo K.; GARCIA, Renato; NETTO, Marcelo V.; BECHARA, Samir J.; WILSON, Steven E.
    PURPOSE: To discuss intraoperative and postoperative femtosecond laser-assisted LASIK flap complications and their management. METHODS: Review of published literature. RESULTS: Flap creation is a critical step in LASIK. The femtosecond laser has improved the overall predictability and safety of the lamellar incision, but complications can still occur during or after flap creation. Although many complications (eg, epithelial ingrowth and flap striae) were reduced with the femtosecond laser application, other specific complications have emerged, such as vertical gas breakthrough, opaque bubble layer, and transient light-sensitivity syndrome. CONCLUSIONS: The application of femtosecond laser technology to LASIK flap creation has increased greatly since its introduction. These lasers have improved the safety and predictability of the lamellar incision step. The majority of the femtosecond laser-assisted flap complications can be well managed without significant effects on refractive outcomes.
  • article 13 Citação(ões) na Scopus
    Corneal Collagen Cross-linking in Advanced Keratoconus: A 4-Year Follow-up Study
    (2016) GIACOMIN, Natalia T.; NETTO, Marcelo V.; TORRICELLI, Andre A. M.; MARINO, Gustavo K.; BECHARA, Samir J.; ESPINDOLA, Rodrigo F.; SANTHIAGO, Marcony R.
    PURPOSE: To analyze the safety and efficacy of standard corneal collagen cross-linking (CXL) in advanced cases of progressive keratoconus after 4 years of follow-up. METHODS: A retrospective case series of patients with advanced progressive keratoconus (stages 3 and 4 of Amsler-Krumeich classification) underwent standard CXL treatment. The parameters examined were changes in uncorrected visual acuity (UDVA), corrected visual acuity (CDVA), keratometry values (mean, flat, steep, and apical), pachymetry, and endothelial cell count at the baseline and at 12, 24, and 48 months postoperatively. RESULTS: Forty eyes of 40 patients were enrolled in the study. The mean patient age was 22.5 years (range: 15 to 37 years). Both mean UDVA and CDVA remained stable during the time points; no statistically significant change was noted. Although a slight reduction was observed in all keratometric readings, a statistically significant reduction was only reached in the apical keratometry (P = .037) at 4 years after CXL. A significant reduction in the corneal thickness was also found (ultrasonic: 388 +/- 49 to 379 +/- 48 mu m; slit-scanning: 362 +/- 48 to 353 +/- 51 mu m); however, this change was likely not clinically meaningful. Endothelial cell count was not significantly different at the end of the study. Treatment failure or progression was noted in two patients (5%) over the follow-up period. CONCLUSIONS: Standard CXL treatment was safe and able to stabilize both visual acuity and topographic parameters at 4 years of follow-up in eyes with advanced keratoconus.